These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 526409)

  • 21. Hemodynamic long-term effects of labetalol in essential hypertension.
    Lund-Johansen P
    Acta Med Scand Suppl; 1979; 625():54-8. PubMed ID: 285576
    [No Abstract]   [Full Text] [Related]  

  • 22. Labetalol in resistant hypertension.
    Dargie HJ; Dollery CT; Daniel J
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):751-5. PubMed ID: 990154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind trial of labetalol.
    Kane J; Gregg I; Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S; Nielsen PE
    Postgrad Med J; 1980; 56 Suppl 2():33-6. PubMed ID: 7433340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of labetalol, a new alpha- and beta-adrenoceptor blocking agent, in humans.
    Vas A; Gachályi B; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):491-2. PubMed ID: 7141757
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
    J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Labetalol in resistant hypertension].
    Stern N; Teicher A; Rosenthal T
    Harefuah; 1981 Aug; 101(3-4):54-6. PubMed ID: 7319385
    [No Abstract]   [Full Text] [Related]  

  • 28. Labetalol for hypertension.
    Drug Ther Bull; 1978 Nov; 16(23):89-90. PubMed ID: 699758
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemodynamic effects of acute and long-term treatment with labetalol.
    Lysbo Svendsen T; Rasmussen S; Nielsen PE; Hartling O; Trap-Jensen J
    Acta Med Scand Suppl; 1979; 625():49-53. PubMed ID: 285575
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetic and haemodynamic studies with labetalol in acute myocardial infarction.
    Silke B; Nelson GI; Ahuja RC; Choudhury S; Taylor SH
    Ir J Med Sci; 1983 May; 152(5):179-86. PubMed ID: 6874287
    [No Abstract]   [Full Text] [Related]  

  • 31. Labetalol infusion for the treatment of hypertension in acute myocardial infarction.
    Timmis AD; Fowler MB; Jaggarao NS; Chamberlain DA
    Eur Heart J; 1980 Dec; 1(6):413-6. PubMed ID: 7274255
    [No Abstract]   [Full Text] [Related]  

  • 32. [Labetalol in the treatment of resistant hypertension].
    Krechnáková A; Danĕková H; Nandoryová M; Niederland TR
    Vnitr Lek; 1981 Jul; 27(7):660-6. PubMed ID: 7303500
    [No Abstract]   [Full Text] [Related]  

  • 33. [Labetalol for the management of hypertensive crises during surgery of cerebral aneurysm; a haemodynamic study (author's transl)].
    Lüben V; Rieder W; Zierski J; Hempelmann G
    Anasth Intensivther Notfallmed; 1981 Aug; 16(4):184-7. PubMed ID: 7294326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Labetalol for hypertension.
    Med Lett Drugs Ther; 1984 Sep; 26(670):83-5. PubMed ID: 6147747
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of labetalol and propranolol in treatment of hypertension.
    Harvald B
    Postgrad Med J; 1980; 56 Suppl 2():65-8. PubMed ID: 7433346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A five-year study of labetalol in hypertension.
    Kane J; Gregg I; Stephens MD
    Practitioner; 1981 Jan; 225(1351):97-8, 100. PubMed ID: 7220466
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared.
    Walker JJ; Greer I; Calder AA
    Postgrad Med J; 1983; 59 Suppl 3():168-70. PubMed ID: 6647203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
    Pugsley DJ; Armstrong BK; Nassim MA; Beilin LJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Labetalol in hypertensive emergencies.
    Br Med J; 1978 Sep; 2(6139):772. PubMed ID: 698718
    [No Abstract]   [Full Text] [Related]  

  • 40. [Labetalol: a new alpha/beta-adrenergic receptor blocking agent].
    Gyimesi A; Hanyecz V; Pocsay G; Iványi J
    Orv Hetil; 1981 Nov; 122(46):2831-4. PubMed ID: 7033885
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.